And if youre not getting enough physical activity to burn those calories, its adding to your waistline
Wegovy (semaglutide injection) is FDA-approved for: Chronic weight management in adults with a BMI of 30+ (obesity), or BMI of 27+ with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol) Weight management in adolescents aged 12 and older with obesity (initial body weight 60 kg) Reducing cardiovascular risk lowering the risk of heart attack, stroke, or cardiovascular death in adults with established cardiovascular disease who are also overweight or have obesity Wegovy is meant to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone treatment
Some providers reduce the dose while maintaining daily frequency
The key is to approach the pairing with intention
It appears to have the most powerful effect on gut health when taken orally, whereas subcutaneous injections are better for reducing systemic inflammation and aiding with tissue repair
Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: iStock/Wegovy Rachel V Thomas Updated Jul 20, 2026 | 10:24 AM IST Summary Novo Nordisk said that Wegovy is the first and only GLP-1 receptor agonist (GLP-1 RA) approved globally and in India for the treatment of noncirrhotic MASH in adults with moderate to advanced liver fibrosis, alongside a reduced-calorie diet and increased physical activity